Joris Wilms Wiel Jan's Insider Trades & SAST Disclosures
Joris Wilms Wiel Jan's most recent trade in Y-Mabs Therapeutics Inc was a trade of 42,900 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 17, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Joris Wilms Wiel Jan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Y-Mabs Therapeutics Inc | Joris Wiel Jan Wilms | SVP & CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 42,900 | 42,900 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Joris Wiel Jan Wilms | SVP & CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 21,500 | 52,100 (0%) | 0% | 0 | Common Stock | |
| Y-Mabs Therapeutics Inc | Joris Wiel Jan Wilms | SVP & CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 14.69 per share. | 26 Aug 2024 | 5,000 | 30,600 (0%) | 0% | 14.7 | 73,450 | Common Stock |
| Y-Mabs Therapeutics Inc | Wiel Jan Wilms Joris | SVP & CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 35,700 | 35,700 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Joris Wilms Wiel Jan | SVP & CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 17,800 | 35,600 (0%) | 0% | 0 | Common Stock | |
| Y-Mabs Therapeutics Inc | Joris Wiel Jan Wilms | SVP & CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 32,000 | 32,000 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Joris Wiel Jan Wilms | SVP & CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 35,700 | 35,700 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Joris Wiel Jan Wilms | SVP & CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 17,800 | 17,800 (0%) | 0% | 0 | Common stock | |
| Y-Mabs Therapeutics Inc | Joris Wiel Jan Wilms | SVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 20,000 | 20,000 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Joris Wiel Jan Wilms | SVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 32,000 | 32,000 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Joris Wiel Jan Wilms | SVP & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 20,000 | 20,000 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges